A multi-center study led by a UB pediatric endocrinologist has found that a drug currently on the market for other autoimmune conditions can preserve the beta cells of children and young adults recently diagnosed with Type 1 diabetes for at least a year after diagnosis. The research, published Nov. 19 in The New England Journal […]
